Carregant...
Identifying “super responders” in pulmonary arterial hypertension
Pharmacotherapeutic options for pulmonary arterial hypertension (PAH) have increased dramatically in the last two decades and along with this have been substantial improvements in survival. Despite these advances, however, PAH remains a progressive and ultimately fatal disease for most patients and...
Guardat en:
| Publicat a: | Pulm Circ |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SAGE Publications
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5467924/ https://ncbi.nlm.nih.gov/pubmed/28597766 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045893217697708 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|